SLS - SELLAS Life Sciences Group files for $200M mixed shelf March, 28 2024 04:54 PM SELLAS Life Sciences Group Inc. 2024-03-28 16:54:11 ET More on SELLAS Life Sciences SELLAS Life Sciences looks to raise $20M in a direct offering Sellas Life Sciences gains on securing orphan drug status for r/r PTCL treatment Seeking Alpha’s Quant Rating on SELLAS Life Sciences For further details see: SELLAS Life Sciences Group files for $200M mixed shelf